Lexicon Genetics is a biopharmaceutical company focused on discovering breakthrough treatments for human diseases, including cancer, diabetes, obesity, cardiovascular disease, cancer, immune system disorders and cancer. It works towards systematically discovering the physiological and behavioral functions of genes to identify potential points of therapeutic intervention or drug targets. Lexicon Genetics engages in programs for the discovery and development of small molecule drugs, therapeutic antibodies and therapeutic proteins. Lexicon Genetics works independently and through strategic collaborations and alliances to accelerate the development and commercialization of its discoveries. Some of these collaborations are with Bristol-Myers Squibb for drug discovery, development and commercialization in the neuroscience field; Genentech to discover the functions of secreted proteins and potential antibody; Organon to jointly discover, develop and commercialize novel biotherapeutics; and Takeda Pharmaceutical Company to accelerate the development and commercialization of new drugs for the treatment of high blood pressure.